Global Pharmaceutical Contract Manufacturing Market

 Big pharma companies increasingly consider outsourcing manufacturing to CMOs as a strategic move because of the uncomplicated, timely and cost-effective services CMOs provide as well as the fact that companies can then focus on their core competencies. This study provides market overview, market engineering measurements, revenue forecasts, competitive analysis, and key trends for the pharmaceutical contract manufacturing market and its segments. 

Regional analysis includes The United States, European countries such as the United Kingdom, Germany, France, Italy, Spain, Benelux, Scandinavia, and Rest of World are covered. The period covered in the study is from 2009 to 2017, with the base year of 2012.

Key Questions This Study Will Answer:

- Is the pharmaceutical contract manufacturing market growing, how long will it continue to grow and at what rate?
- What are the fastest growing segments of the pharmaceutical contract manufacturing market?
- What opportunities exist in the pharmaceutical contract manufacturing industry?
- What are the key drivers and restraints affecting the growth of the CMOs?
- What are the key challenges the CMOs will likely face in the near and long-term future?
- In what ways is the pharmaceutical contract manufacturing industry likely to change to meet industry challenges?

1.Executive Summary
- Scope and Segmentation
- Market Segmentation
- Key Questions This Study Will Answer
- Market Engineering Measurements
- CEO's Perspective
- Key Findings
- Key Companies to Watch
- Executive Summary—3 Big Predictions
- The Last Word—Discussion

2.Market Overview
- Market Segmentation
- Segmentation by Manufacturing Process
- Segmentation by Patent Exclusivity Status
- Global Market Perspective
- Defining CMO Trends in the Future

3.Competitive Playbook
- New Market Opportunities
- Key Merger, Acquisition and Partnership Assessment 

4.Drivers, Restraints, and Trends
- Total Pharmaceutical Contract Manufacturing Market
- Market Drivers
- Market Restraints
- Market Impact of Key Drivers and Restraints 

5. Forecasts and Trends
- Total Pharmaceutical Contract Manufacturing Market
- Market Engineering Measurements
- Forecast Assumptions
- Revenue Forecast
- Revenue Forecast Discussion
- Percent Revenue Forecast by Region
- Revenue Forecast by Region
- Key Market Trends
- Key Technology Trends
- Market Impact of Key Trends
- Venture Capital Trends in CMO
- Segment Lifecycle Analysis 

6. End-User Analysis/Demand Analysis
- Total Pharmaceutical Contract Manufacturing Market
- End-user Survey Objectives
- End-user Survey Methodology
- Outsourcing Trend Analysis by Company Type
- Number of CMOs Companies Work With and by Company Type
- End-user Classification Based on CMO Use
- End-user Breakdown by Company Type
- Criteria for CMO Selection
- Top 5 Factors for CMO Selection
- Top 5 Factors for CMO Selection Discussion
- Stated Versus Unstated Importance of Selection Factors
- Stated Versus Unstated Importance of Selection Factors Discussion
- Extent of Outsourcing to CMOs by Service Areas
- Analysis of Outsourcing Budget Based on Product Revenue
- Outsourcing of Pharmaceutical Manufacturing Demand Forecast
- Industry Capacity Utilisation Forecast
- Industry Capacity Utilisation Forecast Discussion 

7. Market Share and Competitive Analysis
- Total Pharmaceutical Contract Manufacturing Market
- Market Share
- Market Share Analysis
- CMO Breakdown by Finished Dose Segments 

8. Solid Dose Formulations Segment Breakdown
- Solid Dose Formulations Segment Key Findings
- Market Engineering Measurements
- Revenue Forecast
- Revenue Forecast Discussion 

9. Liquid and Semi-solid Dose Formulations Segment Breakdown
- Liquid and Semi-solid Dose Formulations Segment Key Findings
- Market Engineering Measurements
- Revenue Forecast
- Revenue Forecast Discussion 

10. Injectable Dose Formulations Segment Breakdown
- Injectable Dose Formulations Segment Key Findings
- Market Engineering Measurements
- Revenue Forecast
- Revenue Forecast Discussion 

11. United States Breakdown
- US Pharmaceutical Contract Manufacturing Market
- Market Engineering Measurements
- US Pharmaceutical Contract Manufacturing Market Revenue Forecast
- US Pharmaceutical Contract Manufacturing Market Revenue Forecast Discussion
- Solid Dose Formulations Segment Revenue Forecast
- Solid Dose Formulations Segment Revenue Forecast Discussion
- Liquid and Semi-solid Dose Formulations Segment Revenue Forecast
- Liquid and Semi-solid Dose Formulations Segment Revenue Forecast Discussion
- Injectable Dose Formulations Segment Revenue Forecast
- Injectable Dose Formulations Segment Revenue Forecast Discussion
- Pricing Analysis
- Market Analysis
- PESTLE Analysis 

12. Europe Breakdown
- European Pharmaceutical Contract Manufacturing Market
- Market Engineering Measurements
- European Pharmaceutical Contract Manufacturing Market Revenue Forecast
- European Pharmaceutical Contract Manufacturing Market Revenue Forecast Discussion
- Solid Dose Formulations Segment Revenue Forecast
- Solid Dose Formulations Segment Revenue Forecast Discussion
- Liquid and Semi-solid Dose Formulations Segment Revenue Forecast
- Liquid and Semi-solid Dose Formulations Segment Revenue Forecast Discussion
- Injectable Dose Formulations Segment Revenue Forecast
- Injectable Dose Formulations Segment Revenue Forecast Discussion
- Pricing Analysis
- Market Analysis
- PESTLE Analysis 

13. United Kingdom Breakdown
- Solid Dose Formulations Segment Revenue Forecast
- Solid Dose Formulations Segment Revenue Forecast Discussion
- Liquid and Semi-solid Dose Formulations Segment Revenue Forecast
- Liquid and Semi-solid Dose Formulations Segment Revenue Forecast Discussion
- Injectable Dose Formulations Segment Revenue Forecast
- Injectable Dose Formulations Segment Revenue Forecast Discussion 

14. Germany Breakdown
- Solid Dose Formulations Segment Revenue Forecast
- Solid Dose Formulations Segment Revenue Forecast Discussion
- Liquid and Semi-solid Dose Formulations Segment Revenue Forecast
- Liquid and Semi-solid Dose Formulations Segment Revenue Forecast Discussion
- Injectable Dose Formulations Segment Revenue Forecast
- Injectable Dose Formulations Segment Revenue Forecast Discussion 

15. France Breakdown
- Solid Dose Formulations Segment Revenue Forecast
- Solid Dose Formulations Segment Revenue Forecast Discussion
- Liquid and Semi-solid Dose Formulations Segment Revenue Forecast
- Liquid and Semi-solid Dose Formulations Segment Revenue Forecast Discussion
- Injectable Dose Formulations Segment Revenue Forecast
- Injectable Dose Formulations Segment Revenue Forecast Discussion 

16. Italy Breakdown
- Solid Dose Formulations Segment Revenue Forecast
- Solid Dose Formulations Segment Revenue Forecast Discussion
- Liquid and Semi-solid Dose Formulations Segment Revenue Forecast
- Liquid and Semi-solid Dose Formulations Segment Revenue Forecast Discussion
- Injectable Dose Formulations Segment Revenue Forecast
- Injectable Dose Formulations Segment Revenue Forecast Discussion 

17. Spain Breakdown
- Solid Dose Formulations Segment Revenue Forecast
- Solid Dose Formulations Segment Revenue Forecast Discussion
- Liquid and Semi-solid Dose Formulations Segment Revenue Forecast
- Liquid and Semi-solid Dose Formulations Segment Revenue Forecast Discussion
- Injectable Dose Formulations Segment Revenue Forecast
- Injectable Dose Formulations Segment Revenue Forecast Discussion 

18. Scandinavia Breakdown
- Solid Dose Formulations Segment Revenue Forecast
- Solid Dose Formulations Segment Revenue Forecast Discussion
- Liquid and Semi-solid Dose Formulations Segment Revenue Forecast
- Liquid and Semi-solid Dose Formulations Segment Revenue Forecast Discussion
- Injectable Dose Formulations Segment Revenue Forecast
- Injectable Dose Formulations Segment Revenue Forecast Discussion 

19. Benelux Breakdown
- Solid Dose Formulations Segment Revenue Forecast
- Solid Dose Formulations Segment Revenue Forecast Discussion
- Liquid and Semi-solid Dose Formulations Segment Revenue Forecast
- Liquid and Semi-solid Dose Formulations Segment Revenue Forecast Discussion
- Injectable Dose Formulations Segment Revenue Forecast
- Injectable Dose Formulations Segment Revenue Forecast Discussion 

20. Key Companies to Watch
- Key Companies to Watch
- Catalent
- Patheon
- Aenova
- Famar
- Fareva
- Haupt Pharma AG
- Recipharm AB
- DPT Laboratories
- Aesica
- Baxter BioPharma Solutions
- Vetter Pharma
- Hospira One 2 One
- NextPharma Technologies 

21. The Last Word
- The Last Word—Three Big Predictions
- The Last Word—Discussion
- Legal Disclaimer 

22. Appendix
- Market Background
- Important Market Metrics
- Market Landscape and Pricing
- Drivers Explained
- Restraints Explained
- US Patent Expiration Timetable
- Europe Patent Expiration Timetable
- Decision Support Database—Total Healthcare Expenditure
- Decision Support Database—Public Healthcare Expenditure
- Decision Support Database—Private Healthcare Expenditure
- Additional Sources of Information on Contract Outsourcing Services
- List of Other Key Companies Included in this Research Service
- Market Engineering Methodology
- Learn More—Next Steps

List of Exhibits:



- Total Pharmaceutical Contract Manufacturing Market: Market Segmentation, Global, 2012
- Total Pharmaceutical Contract Manufacturing Market: Market Engineering Measurements, Global, 2012
- Total Pharmaceutical Contract Manufacturing Market: Percent Sales Breakdown by Segments, Global, 2012
- Total Pharmaceutical Contract Manufacturing Market: Percent Sales Breakdown by Manufacturing Process, Global, 2012
- Total Pharmaceutical Contract Manufacturing Market: Percent Sales Breakdown by Patent Exclusivity Status, Global, 2012
- Total Pharmaceutical Contract Manufacturing Market: Percent Revenue Breakdown by Geographic Region, Global, 2012
- Total Pharmaceutical Contract Manufacturing Market: Market Outlook, Global, 2012 and 2022
- Total Pharmaceutical Contract Manufacturing Market: Game-changing Strategies, Global, 2012
- Total Pharmaceutical Contract Manufacturing Market: Market Outlook, Global, 2010–2012
- Total Pharmaceutical Contract Manufacturing Market: Key Market Drivers, Global, 2013–2017
- Total Pharmaceutical Contract Manufacturing Market: Key Market Restraints, Global, 2013–2017
- Total Pharmaceutical Contract Manufacturing Market: Impact of Key Drivers and Restraints, Global, 2012
- Total Pharmaceutical Contract Manufacturing Market: Market Engineering Measurements, Global, 2012
- Total Pharmaceutical Contract Manufacturing Market: Revenue Forecast, Global, 2009–2017
- Total Pharmaceutical Contract Manufacturing Market: Percent Points Comparison with the US, Global, 2012
- Total Pharmaceutical Contract Manufacturing Market: Percent Points Manufacturing Cost Comparison with the US, Global, 2012
- Total Pharmaceutical Contract Manufacturing Market: Percent Points Labour Cost Comparison with the US, Global, 2012
- Total Pharmaceutical Contract Manufacturing Market: Percent Revenue Forecast by Region, Global, 2009–2017
- Total Pharmaceutical Contract Manufacturing Market: Revenue Forecast by Region, Global, 2009–2017
- Total Pharmaceutical Market: Combined Prescription Sales for the Top 50 Pharmaceutical Companies by Molecule Type, Global, 2012–2017
- Total Pharmaceutical Market: Combined Prescription Sales for the Top 50 Pharmaceutical Companies by Therapeutic Area, Global, 2012–2017
- Pharmaceutical Contract Manufacturing Market: Percent of Combined Prescription Sales for Big Pharmaceutical Companies by Molecule Type, Global, 2012–2017
- Pharmaceutical Contract Manufacturing Market: Percent of Combined Prescription Sales for Mid-sized Pharmaceutical Companies by Molecule Type, Global, 2012–2017
- Total Pharmaceutical Contract Manufacturing Market: Percent Breakdown of Activities Outsourced, Global, 2012
- Total Pharmaceutical Contract Manufacturing Market: CAGRs of Segments Likely to Have Higher Levels of Outsourcing, Global, 2012–2019
- Total Pharmaceutical Contract Manufacturing Market: Market Impact of Key Trends, Global, 2012
- Total Pharmaceutical Contract Manufacturing Market: Segment Lifecycle Analysis, Global, 2012
- Total Pharmaceutical Contract Manufacturing Market: Percent Finished Dose Manufacturing Outsourced by Company Type, Global, 2012
- Total Pharmaceutical Contract Manufacturing Market: Percent Breakdown of Number of CMOs Companies Work With, Global, 2012
- Total Pharmaceutical Contract Manufacturing Market: Percent Breakdown of Number of CMOs Companies Work With by Company Type, Global, 2012
- Total Pharmaceutical Contract Manufacturing Market: End-user Percent Breakdown by CMO Budget, Global, 2012
- Total Pharmaceutical Contract Manufacturing Market: End-user Percent Breakdown by Company Type, Global, 2012
- Total Pharmaceutical Contract Manufacturing Market: Customer Utility Value of Various Factors Involved in the Selection of a CMO, Global, 2012
- Total Pharmaceutical Contract Manufacturing Market: Percent Breakdown of Top 5 Factors for CMO Selection, Global, 2012
- Total Pharmaceutical Contract Manufacturing Market: Percent Breakdown of Top 5 Factors for CMO Selection by Company Type, Global, 2012
- Total Pharmaceutical Contract Manufacturing Market: Extent of Outsourcing to CMOs by Service Areas, Global, 2012
- Total Pharmaceutical Contract Manufacturing Market: Extent of Outsourcing to CMOs by Service Areas, Global, 2017
- Total Pharmaceutical Contract Manufacturing Market: Percent Outsourcing Budget Allocation Based on Product Revenue, Global, 2012
- Total Pharmaceutical Contract Manufacturing Market: Outsourcing of Pharmaceutical Manufacturing Demand Forecast, Global, 2012–2017
- Total Pharmaceutical Contract Manufacturing Market: Industry Capacity Utilization Forecast, Global, 2012–2017
- Total Pharmaceutical Contract Manufacturing Market: CMO Market Share, Global, 2012
- Total Pharmaceutical Contract Manufacturing Market: CMO Market Share Analysis, Global, 2012
- Total Pharmaceutical Contract Manufacturing Market: CMO Breakdown by Finished Dose Segments, Global, 2012
- Solid Dose Formulations Segment: Percent Sales Breakdown by Sub-segments, Global, 2012
- Solid Dose Formulations Segment: Market Engineering Measurements, Global, 2012
- Solid Dose Formulations Segment: Revenue Forecast, Global, 2009–2017
- Liquid and Semi-solid Dose Formulations Segment: Percent Sales Breakdown by Sub-segments, Global, 2012
- Liquid and Semi-solid Dose Formulations Segment: Market Engineering Measurements, Global, 2012
- Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, Global, 2009–2017
- Injectable Dose Formulations Segment: Percent Sales Breakdown by Sub-segments, Global, 2012
- Injectable Dose Formulations Segment: Market Engineering Measurements, Global, 2012
- Injectable Dose Formulations Segment: Revenue Forecast, Global, 2009–2017
- Pharmaceutical Contract Manufacturing Market: Market Engineering Measurements, US, 2012
- Pharmaceutical Contract Manufacturing Market: Revenue Forecast, US, 2009–2017
- Solid Dose Formulations Segment: Revenue Forecast, US, 2009–2017
- Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, US, 2009–2017
- Injectable Dose Formulations Segment: Revenue Forecast, US, 2009–2017
- Pharmaceutical Contract Manufacturing Market: Pricing Analysis, US, 2012
- Pharmaceutical Contract Manufacturing Market: PESTLE Analysis, US, 2012
- Pharmaceutical Contract Manufacturing Market: Market Engineering Measurements, Europe, 2012
- Pharmaceutical Contract Manufacturing Market: Revenue Forecast, Europe, 2009–2017
- Solid Dose Formulations Segment: Revenue Forecast, Europe, 2009–2017
- Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, Europe, 2009–2017
- Injectable Dose Formulations Segment: Revenue Forecast, Europe, 2009–2017
- Pharmaceutical Contract Manufacturing Market: Pricing Analysis, Europe, 2012
- Pharmaceutical Contract Manufacturing Market: PESTLE Analysis, Europe, 2012
- Solid Dose Formulations Segment: Revenue Forecast, United Kingdom, 2009–2017
- Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast,
- United Kingdom, 2009–2017
- Injectable Dose Formulations Segment: Revenue Forecast, United Kingdom, 2009–2017
- Solid Dose Formulations Segment: Revenue Forecast, Germany, 2009–2017
- Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, Germany, 2009–2017
- Injectable Dose Formulations Segment: Revenue Forecast, Germany, 2009–2017
- Solid Dose Formulations Segment: Revenue Forecast, France, 2009–2017
- Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, France, 2009–2017
- Injectable Dose Formulations Segment: Revenue Forecast, France, 2009–2017
- Solid Dose Formulations Segment: Revenue Forecast, Italy, 2009–2017
- Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, Italy, 2009–2017
- Injectable Dose Formulations Segment: Revenue Forecast, Italy, 2009–2017
- Solid Dose Formulations Segment: Revenue Forecast, Spain, 2009–2017
- Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, Spain, 2009–2017
- Injectable Dose Formulations Segment: Revenue Forecast, Spain, 2009–2017
- Solid Dose Formulations Segment: Revenue Forecast, Scandinavia, 2009–2017
- Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, Scandinavia, 2009–2017
- Injectable Dose Formulations Segment: Revenue Forecast, Scandinavia, 2009–2017
- Solid Dose Formulations Segment: Revenue Forecast, Benelux, 2009–2017
- Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, Benelux, 2009–2017
- Injectable Dose Formulations Segment: Revenue Forecast, Benelux, 2009–2017
- Total Pharmaceutical Contract Manufacturing Market: Important Market Growth Metrics, Global, 2012
- Total Pharmaceutical Contract Manufacturing Market: Client-wise Revenue Contribution to CMOs, Global, 2012
- Total Pharmaceutical Contract Manufacturing Market: VC Investment in Pharmaceutical/Biotech Companies and CMOs, Global, 2000–2011
- Total Pharmaceutical Contract Manufacturing Market: Key Blockbuster Drugs Losing Patent Protection, US, 2012–2017
- Total Pharmaceutical Contract Manufacturing Market: Key Blockbuster Drugs Losing Patent Protection, Europe, 2010–2017
- Decision Support Database: Total Healthcare Expenditure, Global, 2008-2018
- Decision Support Database: Public Healthcare Expenditure, Global, 2008-2018
- Decision Support Database: Private Healthcare Expenditure, Global, 2008-2018